Alere Inc. (ALR)


NYSE - NYSE Real Time Price. Currency in USD
39.13-0.18 (-0.46%)
At close: 4:02 PM EDT
People also watch:
BIOHOLXHAEDXCMCRL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open39.28
Prev Close39.31
Bid39.13 x 300
Ask39.14 x 300
Day's Range38.70 - 39.40
52wk Range31.47 - 54.79
1y Target EstN/A
Market Cap3.39B
P/E Ratio (ttm)-94.98
Beta-0.29
Volume520,385
Avg Vol (3m)1,014,447
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters8 hours ago

    Alere lawsuit accuses Abbott of 'buyer's remorse' in proposed merger

    Alere claims in its complaint that Abbott has avoided responding to a second request by the Federal Trade Commission in a bout of "buyer's remorse" spurred by a desire to free up capital for Abbott's other major planned deal - a $24 billion acquisition of rival St. Jude Medical (STJ.N). Abbott denied the allegations, arguing that Alere's financial problems and related delays in filing its financial statements had slowed the deal's progress. Abbott also said it had been approached by a whistleblower who alleges that Alere is deliberately hiding information about its Indian operations.

  • Reuters8 hours ago

    Alere lawsuit accuses Abbott of 'buyer's remorse' in proposed merger

    Alere Inc alleges Abbott Laboratories is trying to stymie its planned $5.8 billion takeover of the diagnostics company by purposefully delaying key submissions to anti-trust regulators, according to a lawsuit made public on Tuesday. Alere claims in its complaint that Abbott has avoided responding to a second request by the Federal Trade Commission in a bout of "buyer's remorse" spurred by a desire to free up capital for Abbott's other major planned deal - a $24 billion acquisition of rival St. Jude Medical. Abbott denied the allegations, arguing that Alere's financial problems and related delays in filing its financial statements had slowed the deal's progress.

  • TheStreet.com12 hours ago

    Alere (ALR) Stock Lower, Says Abbott Has 'Buyer's Remorse' Over Deal

    In a newly unsealed lawsuit, Alere (ALR) claims that Abbott (ABT) blocked the companies' $7.9 billion merger once it experienced 'buyer's remorse.'